![]() | ![]() |
Formats:
|
||||||||||||||||
Copyright © 2005, The National Academy of Sciences Cell Biology DNA replication origins in the Schizosaccharomyces pombe genome *Department of Molecular Biology and Genetics, The Johns Hopkins University, Baltimore, MD 21205; and ‡Laboratory of Regulation of DNA Replication, Program in Molecular Biology, Sloan–Kettering Institute, New York, NY 10021 § To whom correspondence should be sent at the ‡ address. E-mail: tkelly/at/mskcc.org. †Present address: J. Craig Venter Institute, 9704 Medical Center Drive, Rockville, MD 20850. Contributed by Thomas J. Kelly, November 26, 2004 Freely available online through the PNAS open access option. This article has been cited by other articles in PMC.Abstract Origins of DNA replication in Schizosaccharomyces pombe lack a specific consensus sequence analogous to the Saccharomyces cerevisiae autonomously replicating sequence (ARS) consensus, raising the question of how they are recognized by the replication machinery. Because all well characterized S. pombe origins are located in intergenic regions, we analyzed the sequence properties and biological activity of such regions. The AT content of intergenes is very high (≈70%), and runs of A's or T's occur with a significantly greater frequency than expected. Additionally, the two DNA strands in intergenes display compositional asymmetry that strongly correlates with the direction of transcription of flanking genes. Importantly, the sequence properties of known S. pombe origins of DNA replication are similar to those of intergenes in general. In functional studies, we assayed the in vivo origin activity of 26 intergenes in a 68-kb region of S. pombe chromosome 2. We also assayed the origin activity of sets of randomly chosen intergenes with the same length or AT content. Our data demonstrate that at least half of intergenes have potential origin activity and that the relative ability of an intergene to function as an origin is governed primarily by AT content and length. We propose a stochastic model for initiation of DNA replication in the fission yeast. In this model, the number of AT tracts in a given sequence is the major determinant of its probability of binding SpORC and serving as a replication origin. A similar model may explain some features of origins of DNA replication in metazoans. The replicon model postulates that initiation of DNA replication takes place at specific chromosomal sequence elements (replicators) that are recognized by regulatory proteins (initiators) (1). This model was originally proposed to explain features of the replication of prokaryotic cells and viruses and has been validated in such systems by a large body of evidence (2). In eukaryotic cells, DNA replication is initiated from hundreds to thousands of different chromosomal sites in each cell cycle, raising the question of whether the replicon model provides a valid description of the initiation process. Although early genetic studies indicated that DNA replication in the budding yeast Saccharomyces cerevisiae conforms to the main features of the model, it is not yet clear that this is the case for most other eukaryotic species. Origins of DNA replication in S. cerevisiae were identified as sequence elements that conferred the property of autonomous replication on extrachromosomal plasmids (3). Genetic analysis demonstrated that such autonomously replicating sequences (ARS) were ≈100 bp in length and contained a common 11-bp consensus sequence essential for origin activity, as well as other sequences that augmented origin activity (3–7). The characterization of S. cerevisiae ARS elements led to the identification of the yeast origin recognition complex (ScORC), the initiator protein that recognizes the ARS-consensus sequence (8). The specificity of the interaction of ScORC with origins is quite high. Single base substitutions are sufficient to abolish ScORC binding to the consensus sequence and prevent initiation of DNA replication (8, 9). Origins of DNA replication in Schizosaccharomyces pombe differ in a number of ways from those of S. cerevisiae (10–17). They are very large (>500 bp) and extremely AT-rich. Although they often contain asymmetrically distributed clusters of A's and T's, they do not contain a highly specific consensus sequence analogous to the S. cerevisiae ARS consensus. Genetic studies have shown that S. pombe origins contain multiple redundant elements, which can be deleted or replaced by other AT-rich sequences without significantly affecting activity (14–16, 18). Most of the chromosomal origins that have been analyzed in S. pombe fire in only a minority of cell cycles, suggesting that the number of potential origins is greater than the number actually used in any given cell cycle (11, 13, 17, 19–21). These properties are not easily reconciled with the classical replicon model. The sequencing of the S. pombe genome has made it possible to begin studying the distribution of chromosomal origins of DNA replication (22). Because almost all known S. pombe origins are located in intergenes, we studied the sequence properties and biological activity of such regions. Bioinformatic analysis revealed that the sequences of intergenes (and introns) are not random but exhibit certain underlying patterns that presumably reflect the nature of the mutational mechanisms that operate on the S. pombe genome. The sequence properties of origins of DNA replication are similar to those of intergenes in general. Functional studies of a 68-kb region of S. pombe chromosome 2 demonstrated that more than half of intergenes have potential origin activity and that the relative ability of an intergene to serve as an origin is a function of both its AT content and its length. Based on these and other data we propose that initiation of DNA replication in S. pombe (and perhaps metazoans) conforms to a stochastic model rather than the classical replicon model. Materials and Methods Strains and Media. The S. pombe strain TK47 (h+ ade6-M216 leu1–32) was the recipient strain for transformation assays. Cells were grown in supplemented Edinburgh minimal medium (EMM; Bio 101) at 30°C. EMM6S is EMM supplemented with 250 μg/ml adenine, 250 μg/ml uracil, 250 μg/ml leucine, 250 μg/ml lysine, 250 μg/ml histidine, and 1 mg/ml arginine. EMM-leu is EMM6S without the addition of leucine. Escherichia coli DH5α transformants were grown in Luria–Bertani medium supplemented with 100 μg/ml carbinicilin at 37°C. All solid media contained 2% agar. Construction of Plasmids. Plasmid pRS305 (23) was used as vector for all constructions. Sequence data were downloaded from the Sanger Institute (ftp://ftp.sanger.ac.uk/pub/yeast/pombe/Chromosome_contigs). Twenty-six intergenic regions in 68 kb starting at base pair 2,326,561 (the promoter region of gene SPBC1921.01C) of virtual chromosome 2 (September 5, 2002, release of the S. pombe Genome Project at the Sanger Institute, www.sanger.ac.uk/Projects/S_pombe) were amplified by PCR techniques with oligonucleotide primers containing either a XmaI or SacII site. The PCR products were digested with XmaI and SacII (New England Biolabs) and ligated to pRS305 plasmids that had been digested with the same restriction enzymes. Other intergenes and genes tested in this study were cloned by the same method. Dimeric inserts were generated by a three-fragment ligation. The three fragments were as follows: (i) the large fragment from pRS305 digested with XmaI and SacII, (ii) the PCR product of the intergene cleaved at the 5′ terminus with XbaI or SpeI and at the 3′ terminus with SacII, and (iii) the same PCR product cleaved at the 5′ terminus with XmaI and at the 3′ terminus with XbaI or SpeI. XbaI and SpeI have compatible overhangs and can be joined by ligation. All constructed plasmids were confirmed by sequencing the vector-insert junctions and by restriction digestion as appropriate. ars Activity Assays. Transformation of S. pombe by electroporation was carried out as described in ref. 14. TK47 was grown in EMM6S with shaking at 30°C and harvested at an OD600 of 0.5–0.6 by centrifugation. Cells then were washed once with ice-cold water and once with 1 M ice-cold sorbitol and then resuspended in 1 M sorbitol at 1 × 109 cells per ml. Then, 1 μl of plasmid DNA at a concentration of 100 ng/μl was mixed with 40 μl of cell suspension. After incubation on ice for 5 min, the mixture was transferred to an ice-cold 0.2-cm cuvette (Bio-Rad) immediately before electroporation. Cells were pulsed at 2.0 kV, 200 Ω, and 25 μF by using a Bio-Rad gene pulser. Observed time constants varied between 4.4 and 4.5 ms. Immediately after the pulse, 0.9 ml of ice-cold 1 M sorbitol was added to the cuvette. Aliquots of the transformation were plated onto EMM-leu for selection. Colonies were counted after 5 and 10 days of incubation at 30°C and normalized against pRC20, a plasmid containing ars1 (14). Vector pRS305 was used as a negative control. Software. Programs for analysis of the S. pombe genome were written in the c language and compiled for execution on a Macintosh G3 processor. The genome data were obtained from the Sanger Institute S. pombe Genome Project (www.sanger.ac.uk/Projects/S_pombe). Results Sequence Properties of Intergenes and ars Elements in the S. pombe Genome. To date, approximately 12 S. pombe ars elements have been characterized. The completion of the S. pombe genome sequence has made it possible to determine the chromosomal locations of these elements and to ask whether their sequences have unique features. All of the well characterized ars elements are located in the regions between coding sequences (“intergenic” DNA). There are 4,978 annotated intergenes and 5,006 annotated coding sequences (“genes”) in the S. pombe genome (virtual chromosomes, September 5, 2002, release of the S. pombe Genome Project at the Sanger Institute). The difference between the numbers of intergenes and genes is due to 22 pairs of overlapping genes, 2 pairs of immediately adjacent genes, alternative start codons in 1 gene, and 5 gaps in the sequence. Bioinformatic analysis of the S. pombe genome sequence revealed that the sequences of intergenes are not random but exhibit some underlying patterns. The AT contents of intergenes are much greater than those of genes and, as shown in Fig. 1
The foregoing data indicate that noncoding sequences have drifted toward high AT contents during the evolution of S. pombe. If the mutational and selection pressures accounting for this trend affected each strand equally, we would expect a symmetric base composition, i.e., that A = T and G = C for each of the two strands of an intergene. However, as shown in Fig. 2
The compositions and lengths of previously published S. pombe ars elements and the intergenes that contain them are plotted on the length–composition diagram of Fig. 1 A
Biological Activity of S. pombe Intergenes. To test the ability of S. pombe intergenes to function as origins of DNA replication, we studied a randomly chosen 68-kb contig in chromosome 2 that contained 26 intergenes. Each intergene was cloned into a plasmid that lacked a functional origin of DNA replication and tested for ars activity by the standard assay (see Materials and Methods). The ability to support the autonomous replication of a plasmid is a relatively stringent assay for origin activity, because the long-term maintenance of the plasmid requires that it replicate approximately once each cell cycle. Most S. pombe chromosomal origins fire considerably less frequently than once per cell cycle. We observed that 4 of the 26 intergenes had ars activity by this assay (Fig. 4A
Origin Activity of Intergenes Is a Function of Length and AT Content. Based on their biological activity, the 26 intergenes fell into three classes: (i) those that are active as monomers, (ii) those that are active as dimers, or (iii) those that are not active in the ars assay. Interestingly, the three classes largely clustered in distinct regions of the length–composition diagram (Fig. 4B To further explore the correlation between activity and length or composition, we studied randomly chosen intergenes and genes with the same length (≈1,090 bp) or the same composition (73% AT) (Fig. 5
Discussion Our data indicate that the sequences of intergenes in S. pombe are not random but exhibit certain patterns. These patterns are most likely the result of mutational biases, although it is possible that selection plays a role as well. S. pombe intergenes exhibit three major characteristics. First, the AT contents of intergenes are much higher than those of coding sequences. The drift toward higher AT contents has proceeded to the point that there is little compositional overlap between genes and intergenes. Deamination of cytosine residues (C → T) is probably the major contributor to this drift (24, 25). Second, the sequences of S. pombe intergenes exhibit systematic compositional asymmetry of A and T residues on the two DNA strands. This asymmetry is clearly correlated with the local direction of transcription with A residues significantly more frequent than T residues on the strand that serves as the transcriptional template. The asymmetry is detectable throughout the lengths of the intergenes but is more pronounced on the downstream (3′) side of the coding sequences (Fig. 2 A and B Studies in several laboratories of S. pombe origins of DNA replication have failed to uncover a common consensus sequence analogous to that found in all S. cerevisiae origins. However, several groups have observed that S. pombe origins contain multiple stretches of asymmetric A or T residues (14, 15, 18, 38, 39), some of which have been shown to contribute to origin activity. The results presented here indicate that the sequence properties previously ascribed to origins are actually characteristic of intergenes in general and are not specific to origins. In fact, the only features that appear to distinguish known S. pombe ars elements from the bulk of intergenes are average AT content and length. Our analysis of a 68-kb contig of chromosome 2 demonstrated that intergenes capable of supporting autonomous plasmid replication in vivo are generally long and AT-rich. We also found that many intergenes with shorter lengths and lower AT contents were active in the ars assay after dimerization. Strikingly, the shorter members of this class of intergenes generally had high AT contents, whereas the longer members had low AT contents. Additional studies showed that randomly chosen intergenes with a constant length exhibited ars activity when their AT contents exceeded a threshold value and that randomly chosen intergenes with a constant AT content exhibited ars activity when their lengths exceeded a threshold value. The observation that both length and average AT content contribute to the ability of an intergene to function as an origin suggests that the total AT content is a major determining factor. The density of AT base pairs is important as well because large increases in length are required to compensate for small reductions in AT content (Fig. 4B The conclusion that the efficiency of S. pombe origin activity depends largely on total AT content and is relatively indifferent to the precise nucleotide sequence is supported by both biochemical and genetic data. Biochemical studies have shown that the S. pombe origin recognition complex is targeted to origins by the N-terminal domain of SpOrc4, which contains nine AT-hook motifs (40–43). The AT-hook motif binds to short AT tracts of 4–6 nt in length in the minor groove of DNA (44). Proteins that contain multiple AT-hook motifs, like HMGA [HMGI(Y)], can bind to multiple AT tracts in close proximity (45). In this case, the overall affinity of the protein for the site depends on the spacing of the AT tracts and, to a lesser extent, on the length of the AT tracts. For example, in the case of HMGA, which has three AT hooks and can bind with high affinity to three adjacent AT tracts, the optimum spacing between the tracts is in the range of 4–8 nt. When the spacing becomes significantly larger (e.g., 12 nt), a single HMGA molecule no longer can span all three sites, and the binding affinity is much lower (45). Because SpOrc4 has nine AT hooks, it would be expected that there would be many possible ways that it could interact with a sequence containing multiple AT tracts (e.g., an intergene). The affinity of each possible binding mode would be determined largely by the number of AT hooks engaged, which would in turn depend on the spacing of the AT tracts. Thus, the overall affinity of SpOrc4 for such a sequence would be a complex function of the number of possible binding modes and the binding affinity of each mode and would be expected to increase with AT content and length. Consistent with these ideas, it has been demonstrated experimentally that SpOrc4 has significant affinity for multiple sites within a single ars element (41–43, 46). Moreover, genetic studies have shown that sequences capable of functioning as origins contain multiple redundant AT-rich elements that contribute to activity (14–16, 18, 38). It has been shown in some cases that such AT-rich elements can be replaced by different AT-rich sequences without significant loss of activity (15). Thus, the picture of S. pombe origins that emerges from these considerations is quite different from the classical replicon model, which postulates that the initiator protein binds a limited number of sites with high specificity (1). Instead, the initiation of S. pombe DNA replication is likely to be a much more stochastic process. In the stochastic model shown in Fig. 6
Several lines of evidence suggest that the stochastic model may be relevant to initiation of DNA replication in mammalian cells. In several cases initiation has been shown to occur with relatively low efficiency at many different sites in intergenic regions of the genome (47, 48). Recent work suggests that human ORC binds preferentially to AT-rich sequences but otherwise has little sequence specificity (49). Moreover, recombinant human ORC can direct initiation of DNA replication on any DNA molecule in a cell-free replication system (49). Although these observations are clearly consistent with a stochastic model, there are other instances where initiation of mammalian DNA replication appears to be localized to relatively small regions of the chromosome, indicating that ORC binding and/or initiation are not completely random in mammalian cells (50). Such regions are generally intergenic and often AT-rich. As in the case of the AT-rich intergenes of S. pombe, these regions simply may contain a high density of potential ORC binding sites, or, alternatively, the localization of initiation may depend on specific features of chromatin structure. Supporting Table
Acknowledgments We thank Pamela Simancek and Deborah Tien for technical assistance and the other members of the Kelly laboratory for stimulating discussions. This work was supported by National Institutes of Health Grants CA40414 and GM50806. Notes Author contributions: J.D., R.-Y.C., and T.J.K. designed research; J.D. and T.J.K. performed research; J.D., R.-Y.C., and T.J.K. contributed new reagents/analytic tools; J.D. and T.J.K. analyzed data; and J.D. and T.J.K. wrote the paper. Abbreviations: ARS, autonomously replicating sequence; ORC, origin recognition complex. References 1. Jacob, F. & Brenner, S. (1963. ) Comptes Rendus Hebdomadaires Seances Acad. Sci. 256, 298-300. 2. Kornberg, A. & Baker, T. A. (1992. ) DNA Replication (Freeman, New York). 3. Newlon, C. S. & Theis, J. F. (1993. ) Curr. Opin. Genet. Dev. 3, 752-758. [PubMed] 4. Yabuki, N., Terashima, H. & Kitada, K. (2002. ) Genes Cells 7, 781-789. [PubMed] 5. Wyrick, J. J., Aparicio, J. G., Chen, T., Barnett, J. D., Jennings, E. G., Young, R. A., Bell, S. P. & Aparicio, O. M. (2001. ) Science 294, 2357-2360. [PubMed] 6. Raghuraman, M. K., Winzeler, E. A., Collingwood, D., Hunt, S., Wodicka, L., Conway, A., Lockhart, D. J., Davis, R. W., Brewer, B. J. & Fangman, W. L. (2001. ) Science 294, 115-121. [PubMed] 7. Breier, A. M., Chatterji, S. & Cozzarelli, N. R. (March 4, 2004. ) Genome Biol. 5, R22. Available at http://genomebiology.com/2004/5/4/R22. [PubMed] 8. Bell, S. P. & Stillman, B. (1992. ) Nature 357, 128-134. [PubMed] 9. Van Houten, J. V. & Newlon, C. S. (1990. ) Mol. Cell. Biol. 10, 3917-3925. [PubMed] 10. Maundrell, K., Hutchison, A. & Shall, S. (1988. ) EMBO J. 7, 2203-2209. [PubMed] 11. Dubey, D. D., Zhu, J., Carlson, D. L., Sharma, K. & Huberman, J. A. (1994. ) EMBO J. 13, 3638-3647. [PubMed] 12. Johnston, L. H. & Barker, D. G. (1987. ) Mol. Gen. Genet. 207, 161-164. [PubMed] 13. Caddle, M. S. & Calos, M. P. (1994. ) Mol. Cell. Biol. 14, 1796-1805. [PubMed] 14. Clyne, R. K. & Kelly, T. J. (1995. ) EMBO J. 14, 6348-6357. [PubMed] 15. Okuno, Y., Satoh, H., Sekiguchi, M. & Masukata, H. (1999. ) Mol. Cell. Biol. 19, 6699-6709. [PubMed] 16. Kim, S. M. & Huberman, J. A. (1998. ) Mol. Cell. Biol. 18, 7294-7303. [PubMed] 17. Segurado, M., de Luis, A. & Antequera, F. (2003. ) EMBO Rep. 4, 1048-1053. [PubMed] 18. Kim, S. M., Zhang, D. Y. & Huberman, J. A. (2001. ) BMC Mol Biol., 10.1186/1471–2199-2–1. 19. Smith, J. G., Caddle, M. S., Bulboaca, G. H., Wohlgemuth, J. G., Baum, M., Clarke, L. & Calos, M. P. (1995. ) Mol. Cell. Biol. 15, 5165-5172. [PubMed] 20. Wohlgemuth, J. G., Bulboaca, G. H., Moghadam, M., Caddle, M. S. & Calos, M. P. (1994. ) Mol. Biol. Cell 5, 839-849. [PubMed] 21. Okuno, Y., Okazaki, T. & Masukata, H. (1997. ) Nucleic Acids Res. 25, 530-537. [PubMed] 22. Wood, V., Gwilliam, R., Rajandream, M. A., Lyne, M., Lyne, R., Stewart, A., Sgouros, J., Peat, N., Hayles, J., Baker, S., et al. (2002. ) Nature 415, 871-880. [PubMed] 23. Sikorski, R. S. & Hieter, P. (1989. ) Genetics 122, 19-27. [PubMed] 24. Fryxell, K. J. & Zuckerkandl, E. (2000. ) Mol. Biol. Evol. 17, 1371-1383. [PubMed] 25. Sueoka, N. (2002. ) Gene 300, 141-154. [PubMed] 26. Munoz, M. J., Daga, R. R., Garzon, A., Thode, G. & Jimenez, J. (2002. ) Mol. Genet. Genomics 267, 792-796. [PubMed] 27. Humphrey, T., Birse, C. E. & Proudfoot, N. J. (1994. ) EMBO J. 13, 2441-2451. [PubMed] 28. Birse, C. E., Lee, B. A., Hansen, K. & Proudfoot, N. J. (1997. ) EMBO J. 16, 3633-3643. [PubMed] 29. Patrikakis, M., Izant, J. G. & Atkins, D. (1996. ) Curr. Genet. 30, 151-158. [PubMed] 30. Hansen, K., Birse, C. E. & Proudfoot, N. J. (1998. ) EMBO J. 17, 3066-3077. [PubMed] 31. Niu, D. K., Lin, K. & Zhang, D. Y. (2003. ) J. Mol. Evol. 57, 325-334. [PubMed] 32. Beletskii, A. & Bhagwat, A. S. (1996. ) Proc. Natl. Acad. Sci. USA 93, 13919-13924. [PubMed] 33. Francino, M. P. & Ochman, H. (2001. ) Mol. Biol. Evol. 18, 1147-1150. [PubMed] 34. Oller, A. R., Fijalkowska, I. J., Dunn, R. L. & Schaaper, R. M. (1992. ) Proc. Natl. Acad. Sci. USA 89, 11036-11040. [PubMed] 35. Hanawalt, P. C. (1995. ) Mutat. Res. 336, 101-113. [PubMed] 36. Green, P., Ewing, B., Miller, W., Thomas, P. J. & Green, E. D. (2003. ) Nat. Genet. 33, 514-517. [PubMed] 37. Tautz, D. & Schlotterer (1994. ) Curr. Opin. Genet. Dev. 4, 832-837. [PubMed] 38. Dubey, D. D., Kim, S. M., Todorov, I. T. & Huberman, J. A. (1996. ) Curr. Biol. 6, 467-473. [PubMed] 39. Clyne, R. K. & Kelly, T. J. (1997. ) Methods 13, 221-233. [PubMed] 40. Chuang, R. Y. & Kelly, T. J. (1999. ) Proc. Natl. Acad. Sci. USA 96, 2656-2661. [PubMed] 41. Chuang, R. Y., Chretien, L., Dai, J. & Kelly, T. J. (2002. ) J. Biol. Chem. 277, 16920-16927. [PubMed] 42. Lee, J. K., Moon, K. Y., Jiang, Y. & Hurwitz, J. (2001. ) Proc. Natl. Acad. Sci. USA 98, 13589-13594. [PubMed] 43. Kong, D. & DePamphilis, M. L. (2001. ) Mol. Cell. Biol. 21, 8095-8103. [PubMed] 44. Reeves, R. (2001. ) Gene 277, 63-81. [PubMed] 45. Maher, J. F. & Nathans, D. (1996. ) Proc. Natl. Acad. Sci. USA 93, 6716-6720. [PubMed] 46. Takahashi, T., Ohara, E., Nishitani, H. & Masukata, H. (2003. ) EMBO J. 22, 964-974. [PubMed] 47. Dijkwel, P. A., Vaughn, J. P. & Hamlin, J. L. (1994. ) Nucleic Acids Res. 22, 4989-4996. [PubMed] 48. Dijkwel, P. A., Mesner, L. D., Levenson, V. V., d'Anna, J. & Hamlin, J. L. (2000. ) Exp. Cell Res. 256, 150-157. [PubMed] 49. Vashee, S., Cvetic, C., Lu, W., Simancek, P., Kelly, T. J. & Walter, J. C. (2003. ) Genes Dev. 17, 1894-1908. [PubMed] 50. Gilbert, D. M. (2001. ) Science 294, 96-100. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||
Curr Opin Genet Dev. 1993 Oct; 3(5):752-8.
[Curr Opin Genet Dev. 1993]Genome Biol. 2004; 5(4):R22.
[Genome Biol. 2004]Nature. 1992 May 14; 357(6374):128-34.
[Nature. 1992]Mol Cell Biol. 1990 Aug; 10(8):3917-25.
[Mol Cell Biol. 1990]EMBO J. 1988 Jul; 7(7):2203-9.
[EMBO J. 1988]EMBO Rep. 2003 Nov; 4(11):1048-53.
[EMBO Rep. 2003]EMBO J. 1995 Dec 15; 14(24):6348-57.
[EMBO J. 1995]Mol Cell Biol. 1998 Dec; 18(12):7294-303.
[Mol Cell Biol. 1998]EMBO J. 1994 Aug 1; 13(15):3638-47.
[EMBO J. 1994]Nature. 2002 Feb 21; 415(6874):871-80.
[Nature. 2002]Genetics. 1989 May; 122(1):19-27.
[Genetics. 1989]EMBO J. 1995 Dec 15; 14(24):6348-57.
[EMBO J. 1995]EMBO J. 1988 Jul; 7(7):2203-9.
[EMBO J. 1988]Nucleic Acids Res. 1997 Feb 1; 25(3):530-7.
[Nucleic Acids Res. 1997]Mol Biol Cell. 1994 Aug; 5(8):839-49.
[Mol Biol Cell. 1994]Mol Biol Evol. 2000 Sep; 17(9):1371-83.
[Mol Biol Evol. 2000]Gene. 2002 Oct 30; 300(1-2):141-54.
[Gene. 2002]Mol Genet Genomics. 2002 Aug; 267(6):792-6.
[Mol Genet Genomics. 2002]EMBO J. 1998 Jun 1; 17(11):3066-77.
[EMBO J. 1998]J Mol Evol. 2003 Sep; 57(3):325-34.
[J Mol Evol. 2003]EMBO J. 1995 Dec 15; 14(24):6348-57.
[EMBO J. 1995]Mol Cell Biol. 1999 Oct; 19(10):6699-709.
[Mol Cell Biol. 1999]Curr Biol. 1996 Apr 1; 6(4):467-73.
[Curr Biol. 1996]Methods. 1997 Nov; 13(3):221-33.
[Methods. 1997]EMBO Rep. 2003 Nov; 4(11):1048-53.
[EMBO Rep. 2003]Proc Natl Acad Sci U S A. 1999 Mar 16; 96(6):2656-61.
[Proc Natl Acad Sci U S A. 1999]Mol Cell Biol. 2001 Dec; 21(23):8095-103.
[Mol Cell Biol. 2001]Gene. 2001 Oct 17; 277(1-2):63-81.
[Gene. 2001]Proc Natl Acad Sci U S A. 1996 Jun 25; 93(13):6716-20.
[Proc Natl Acad Sci U S A. 1996]J Biol Chem. 2002 May 10; 277(19):16920-7.
[J Biol Chem. 2002]EMBO J. 1994 Aug 1; 13(15):3638-47.
[EMBO J. 1994]Mol Cell Biol. 1994 Mar; 14(3):1796-805.
[Mol Cell Biol. 1994]EMBO Rep. 2003 Nov; 4(11):1048-53.
[EMBO Rep. 2003]Mol Cell Biol. 1995 Sep; 15(9):5165-72.
[Mol Cell Biol. 1995]Nucleic Acids Res. 1997 Feb 1; 25(3):530-7.
[Nucleic Acids Res. 1997]Nucleic Acids Res. 1994 Nov 25; 22(23):4989-96.
[Nucleic Acids Res. 1994]Exp Cell Res. 2000 Apr 10; 256(1):150-7.
[Exp Cell Res. 2000]Genes Dev. 2003 Aug 1; 17(15):1894-908.
[Genes Dev. 2003]Science. 2001 Oct 5; 294(5540):96-100.
[Science. 2001]